D.E. Shaw & Co
APLS

D.E. Shaw & Co’s Apellis Pharmaceuticals APLS Stock Holding History

D.E. Shaw & Co’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,000
Closed -$377K – 4516
2025
Q4 		$377K Hold
15,000
– – ﹤0.01% 4057
2025
Q3 		$339K Sell
15,000
-7,700
-34% -$180K ﹤0.01% 4049
2025
Q2 		$393K Sell
22,700
-15,400
-40% -$285K ﹤0.01% 3743
2025
Q1 		$833K Buy
38,100
+7,100
+23% +$196K ﹤0.01% 3201
2024
Q4 		$989K Buy
+31,000
New +$932K ﹤0.01% 3208

Other funds holding APLS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return